MedPath

Efficacy of the ROCK inhibitor for corneal endothelial protection in Fuchs' endothelial corneal dystrophy after cataract surgery

Phase 3
Conditions
endothelial cell loss in cataract surgery in Fuchs endothelial corneal dystrophy
Registration Number
TCTR20220602005
Lead Sponsor
THE 90TH ANNIVERSARY OF CHULALONGKORN UNIVERSITY FUND ( Ratchadaphiseksomphot Endowment Fund)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
nknown
Sex
All
Target Recruitment
56
Inclusion Criteria

1. Age 40-90 years old
2. Diagnosis of FECD with modified Krachmer grade 1-4 and visual significance cataract with eligible for phacoemulsification with intraocular lens implantation
3. Central endothelial cell count > 1,000 cell/mm2
4. Paracentral endothelial cell count > 1,000 cell/mm2 in all superior /inferior/nasal/temporal quadrant
5. Central corneal thickness < 640 micron
6. Cataract grading: nuclear hardness graded by the Emery-Little classification 1-3
7. Willingness to regular follow-up as appointed

Exclusion Criteria

1. History of severe ocular trauma with lens subluxation
2. Corneal scar
3. History of corneal laser vision correction
4. Use of ripasudil before enrollment in the study
5. Active allergy, infection, inflammation at ocular surface
6. Unstable systemic diseases: uncontrolled HT, uncontrolled DM, stroke, coronary artery disease, cerebrovascular disease, bleeding diathesis
7. History of allergy to ripasudil
8. Phacoemulsification with major intraoperative complication such as large posterior capsular tear or zonule dialysis more than 90 degrees

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
% Endothelial cell loss 6 months after surgery specular microscopy
Secondary Outcome Measures
NameTimeMethod
central corneal thickness 6 months after surgery ultrasound pachymetry
© Copyright 2025. All Rights Reserved by MedPath